| Bos taurus |
Aldose reductase |
Inhibition |
9.0 |
% |
10.1021/jm00102a016 |
| Bos taurus |
Aldose reductase |
Inhibition |
nan |
% |
10.1021/jm00102a016 |
| Bos taurus |
Progesterone receptor |
IC50 |
29118.0 |
nM |
None |
| Bos taurus |
Progesterone receptor |
Ki |
3798.0 |
nM |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Equus caballus |
Ferritin light chain |
Potency |
14125.4 |
nM |
None |
| Equus caballus |
Ferritin light chain |
Potency |
35481.3 |
nM |
None |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
5000.0 |
nM |
10.1021/acs.jmedchem.2c01097 |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
IC50 |
2700.0 |
nM |
10.1016/j.bmcl.2013.11.081 |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
IC50 |
2700.0 |
nM |
10.1016/j.ejmech.2017.02.031 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
15026.0 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
3047.0 |
nM |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
1722.0 |
nM |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
16551.0 |
nM |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
6207.0 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
13258.0 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
6053.0 |
nM |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
AMP-activated protein kinase, AMPK |
Activity |
nan |
None |
10.1021/jm901773d |
| Homo sapiens |
Androgen Receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aryl hydrocarbon receptor |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
17871.0 |
nM |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
13403.0 |
nM |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
37800.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
37800.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
86.0 |
nM |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
Ki |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
IC50 |
26894.0 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
9481.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
19785.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
9893.0 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
26704.0 |
nM |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
9069.0 |
nM |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
EA.hy 926 |
Activity |
nan |
None |
10.1016/j.bmc.2008.10.083 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
4655.0 |
nM |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
8414.4 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-53.56 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
1.94 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LNCaP |
Activity |
nan |
None |
10.1021/jm300015m |
| Homo sapiens |
LNCaP |
Activity |
nan |
None |
10.1021/jm701212m |
| Homo sapiens |
LNCaP |
IC50 |
60000.0 |
nM |
10.1021/jm300015m |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
28621.0 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
26848.0 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
29193.0 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase B |
IC50 |
225.0 |
nM |
10.1016/j.bmcl.2010.06.128 |
| Homo sapiens |
Monoamine oxidase B |
IC50 |
225.0 |
nM |
10.1016/j.bmcl.2022.128994 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
21107.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
7505.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
14947.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
3168.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
16224.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
2263.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
12576.0 |
nM |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
4192.0 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
2220.0 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
2201.0 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
9688.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
76958.8 |
nM |
None |
| Homo sapiens |
PC-3 |
FC |
0.934 |
None |
10.1038/nchembio790 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.024 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.024 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
2.5 |
None |
10.1021/jm701212m |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.024 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1021/jm901773d |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1021/np050397q |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
3000.0 |
nM |
10.1007/s00044-010-9428-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
14900.0 |
nM |
10.1021/np010440j |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
22908.68 |
nM |
10.1021/jm9804127 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
FC |
3.65 |
None |
10.1021/np400780n |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
FC |
15.0 |
None |
10.1021/np010440j |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
IC50 |
5000.0 |
nM |
10.1016/j.bmc.2018.10.033 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Ki |
3090.3 |
nM |
10.1021/jm9804127 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
EC50 |
4500.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
10000.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
14100.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
84.1 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
96.1 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
108.0 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
188.9 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Ribosomal protein S6 kinase 1 |
Activity |
nan |
None |
10.1021/jm901773d |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
IC50 |
14948.0 |
nM |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
7941.0 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Signal transducer and activator of transcription 3 |
Activity |
nan |
None |
10.1021/jm901773d |
| Homo sapiens |
THP-1 |
Activity |
nan |
None |
10.1021/jm901773d |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
31.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8414.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Mus musculus |
3T3-L1 |
Effect |
151.3 |
% |
10.1021/jm00067a023 |
| Mus musculus |
3T3-L1 |
GT fold stimulation |
1.49 |
None |
10.1021/jm00105a050 |
| Mus musculus |
3T3-L1 |
GT fold stimulation |
1.51 |
None |
10.1021/jm00105a050 |
| Mus musculus |
Mus musculus |
Activity |
70.0 |
% |
10.1021/jm00083a021 |
| Mus musculus |
Mus musculus |
Change |
-28.0 |
% |
10.1021/jm00004a008 |
| Mus musculus |
Mus musculus |
Decrease |
-35.0 |
% |
10.1021/jm00167a022 |
| Mus musculus |
Mus musculus |
Decrease |
-29.0 |
% |
10.1021/jm00085a002 |
| Mus musculus |
Mus musculus |
Decrease |
-15.0 |
% |
10.1021/jm00085a002 |
| Mus musculus |
Mus musculus |
Decrease |
7.9 |
% |
10.1021/jm00122a022 |
| Mus musculus |
Mus musculus |
Decrease |
10.8 |
% |
10.1021/jm00122a022 |
| Mus musculus |
Mus musculus |
Decrease |
15.0 |
% |
10.1021/jm9706168 |
| Mus musculus |
Mus musculus |
Decrease |
18.7 |
% |
10.1021/jm00122a022 |
| Mus musculus |
Mus musculus |
Decrease |
32.0 |
% |
10.1021/jm00102a016 |
| Mus musculus |
Mus musculus |
Decrease |
32.0 |
% |
10.1021/jm9706168 |
| Mus musculus |
Mus musculus |
Decrease |
32.0 |
% |
10.1021/jm990476x |
| Mus musculus |
Mus musculus |
Decrease |
39.0 |
% |
10.1021/jm9706168 |
| Mus musculus |
Mus musculus |
Decrease |
43.0 |
% |
10.1021/jm9706168 |
| Mus musculus |
Mus musculus |
DOSE |
35.7 |
mg.kg-1 |
10.1021/jm00122a022 |
| Mus musculus |
Mus musculus |
ED25 |
25.0 |
mg kg-1 day-1 |
10.1021/jm00092a012 |
| Mus musculus |
Mus musculus |
ED25 |
25.0 |
mg kg-1 day-1 |
10.1021/jm010490l |
| Mus musculus |
Mus musculus |
ED25 |
31.0 |
mg kg-1 day-1 |
10.1021/jm00092a012 |
| Mus musculus |
Mus musculus |
Glucose level |
189.0 |
mg dl-1 |
10.1021/jm00069a006 |
| Mus musculus |
Mus musculus |
Glucose normalisation |
52.0 |
% |
10.1021/jm00105a050 |
| Mus musculus |
Mus musculus |
Glucose normalisation |
84.0 |
% |
10.1021/jm00105a050 |
| Mus musculus |
Mus musculus |
Inhibition |
39.0 |
% |
10.1021/jm990260v |
| Mus musculus |
Mus musculus |
Inhibition |
43.0 |
% |
10.1021/jm990260v |
| Mus musculus |
Mus musculus |
MED |
3000.0 |
uM kg-1 |
10.1021/jm950395a |
| Mus musculus |
Mus musculus |
MED |
3000.0 |
uM.kg/diet |
10.1016/S0960-894X(01)80325-5 |
| Mus musculus |
Mus musculus |
Normalization |
100.0 |
% |
10.1021/jm00088a022 |
| Mus musculus |
Mus musculus |
Plasma glucose |
107.0 |
mg dl-1 |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma glucose |
191.0 |
mg dl-1 |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma glucose |
320.0 |
mg dl-1 |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma glucose |
348.0 |
mg dl-1 |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma glucose level |
285.0 |
mg dl-1 |
10.1021/jm00167a022 |
| Mus musculus |
Mus musculus |
Plasma glucose level |
313.0 |
mg dl-1 |
10.1021/jm00167a022 |
| Mus musculus |
Mus musculus |
Plasma insulin |
20.0 |
ml |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma insulin |
25.0 |
ml |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma insulin |
94.0 |
ml |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Plasma insulin |
117.0 |
ml |
10.1021/jm00121a003 |
| Mus musculus |
Mus musculus |
Reduction |
41.0 |
% |
10.1021/jm00049a017 |
| Mus musculus |
Mus musculus |
Reduction |
nan |
None |
10.1021/jm00049a017 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
12589.3 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
Peroxisome proliferator-activated receptor alpha |
EC50 |
nan |
nM |
10.1021/jm950395a |
| Mus musculus |
Peroxisome proliferator-activated receptor delta |
EC50 |
nan |
nM |
10.1021/jm950395a |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.bmcl.2009.02.004 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
Displacement |
81.0 |
% |
10.1021/jm950395a |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
EC50 |
3000.0 |
nM |
10.1021/jm950395a |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
16136.6 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1016/j.bmcl.2004.02.087 |
| Rattus norvegicus |
PC-12 |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2004.02.087 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
18105.6 |
nM |
None |
| Rattus norvegicus |
Protein-tyrosine phosphatase 1B |
Inhibition |
20.0 |
% |
10.1021/jm990476x |
| Rattus norvegicus |
Rattus norvegicus |
Blood lactate |
8.0 |
mg dl-1 |
10.1021/jm00167a022 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
0.1 |
ug.mL-1 |
10.1021/jm00122a022 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1021/jm00102a016 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma glucose level |
83.0 |
mg dl-1 |
10.1021/jm00167a022 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
Hepatotoxicity |
DILI positive/negative |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Molecular identity unknown |
Potency |
44668.4 |
nM |
None |
| None |
No relevant target |
CLogP |
3.57 |
None |
10.1016/S0960-894X(01)80325-5 |
| None |
No relevant target |
LogP |
3.61 |
None |
10.1021/jm00004a008 |
| None |
No relevant target |
LogP |
5.07 |
None |
10.1016/j.bmcl.2004.02.087 |
| None |
No relevant target |
pKa |
6.82 |
None |
10.1021/jm00167a022 |
| None |
No relevant target |
pKa |
7.8 |
None |
10.1021/jm00004a008 |
| None |
Unchecked |
2-DG uptake stimulation |
0.68 |
None |
10.1021/jm00105a050 |
| None |
Unchecked |
2-DG uptake stimulation |
0.82 |
None |
10.1021/jm00105a050 |
| None |
Unchecked |
2-DG uptake stimulation |
1.02 |
None |
10.1021/jm00105a050 |
| None |
Unchecked |
Ac50 |
1.0 |
uM |
None |
| None |
Unchecked |
AC50 |
1000.0 |
nM |
None |
| None |
Unchecked |
Activity |
31.0 |
None |
10.1021/jm010490l |
| None |
Unchecked |
IC50 |
78000.0 |
nM |
10.1021/jm300015m |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |